首頁 > 市場調查報告書 > 材料

玻璃

市場調查報告書

商品編碼

1309273

全球藥用玻璃包裝市場規模：按產品類型、按藥物類型、按用途、按材料類型 - 區域預測、競爭策略、細分市場預測 (～2033年)

Pharmaceutical Glass Packaging Market Size- By Product, By Drug Type, By Application, By Material Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: 2023年06月23日 | 出版商:

SPER Market Research Pvt. Ltd. | 英文 224 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計到2033年，全球藥用玻璃包裝市場規模將達到492.4億美元，年複合成長率為9.41%。

本報告提供了全球藥用玻璃包裝市場的研究分析，提供市場動態、區域和細分分析、公司概況等。

全球藥用玻璃包裝市場規模及市場佔有率：按地區分類（2019-2026）
全球藥用玻璃包裝市場規模及市場佔有率：按地區分類（2027-2033）
亞太地區
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太地區其他地區
歐洲
- 法國
- 德國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
中東/非洲
- 沙烏地阿拉伯王國
- 阿拉伯聯合大公國
- 其他中東/非洲
北美
- 加拿大
- 墨西哥
- 美國
拉丁美洲
- 阿根廷
- 巴西
- 其他拉丁美洲

第17章公司簡介

Arab Pharmaceutical Glass Co.
Ardagh Group SA
Beatson Clark
Bormioli Pharma SpA
Corning Incorporated
Gerresheimer AG
Nipro Corporation
Owens-Illinois, Inc.
Piramal Enterprises Ltd.
Schott AG
SGD SA
Shandong Medicinal Glass Co., Ltd.
Sisecam Group
Stoelzle Oberglas GmbH
West Pharmaceutical Services, Inc.
其他

第18章縮略語表

第19章參考鏈接

第20章結論

第21章調查範圍

簡介目錄

Product Code: PACK2316

Pharmaceutical Glass Packaging Market Overview

According to SPER market research, 'Pharmaceutical Glass Packaging Market Size- By Product, By Drug Type, By Application, By Material Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Pharmaceutical Glass Packaging Market is predicted to reach USD 49.24 billion by 2033 with a CAGR of 9.41%.

Pharmaceutical glass packaging involves the use of glass materials to package medications and other pharmaceutical products. Glass is preferred for its protective properties, safeguarding drugs against various external factors such as air, moisture, light, temperature changes, and chemical interactions. This ensures the medications remain effective and stable over time. Glass is chemically inert, preventing any unwanted reactions or degradation of the drugs, thereby maintaining their purity and potency.

the COVID-19 widespread has cleared out the pharmaceutical industry with consistently developing a high demand for medications and other healthcare facilities. The surge in demand for pharmaceutical drugs, as a result of the pandemic, has influenced the market in a positive manner. The demand is predicted to reach a new apex, depending on approvals for new COVID-19 immunizations created by various institutions and companies in different nations.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Product, By Drug Type, By Application, By Material Type

Regions covered Asia-Pacific, Latin America, Middle East and Africa, North America, Europe

Companies Covered Arab Pharmaceutical Glass Co., Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Owens-Illinois, Inc., Piramal Enterprises Ltd., Schott AG, SGD S.A., Shandong Medicinal Glass Co.,

Pharmaceutical Glass Packaging Market Key Segments Covered

By Product: Based on the Product, Global Pharmaceutical Glass Packaging Market is segmented as; Ampoules, Bottles, Cartridges, Syringes, Vials.

By Drug Type: Based on the Drug Type, Global Pharmaceutical Glass Packaging Market is segmented as; Biologic, Branded, Generic.

By Application: Based on the Application, Global Pharmaceutical Glass Packaging is segmented as; Injectable, Nasal, Oral, Topical, Others.

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Pharmaceutical Glass Packaging Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Pharmaceutical Glass Packaging Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pharmaceutical Glass Packaging Market

7. Global Pharmaceutical Glass Packaging Market, By Product (USD Million)

7.1. Global Pharmaceutical Glass Packaging Market Value Share and Forecast, By Product, 2023-2033
7.2. Ampoules
7.3. Bottles
7.4. Cartridges
7.5. Syringes
7.6. Vials

8. Global Pharmaceutical Glass Packaging Market, By Drug Type (USD Million)

8.1. Global Pharmaceutical Glass Packaging Market Value Share and Forecast, By Drug Type, 2023-2033
8.2. Biologic
8.3. Branded
8.4. Generic

9. Global Pharmaceutical Glass Packaging Market, By Application (USD Million)

9.1. Global Pharmaceutical Glass Packaging Market Value Share and Forecast, By Application, 2023-2033
9.2. Injectable
9.3. Nasal
9.4. Oral
9.5. Topical
9.6. Others

10. Global Pharmaceutical Glass Packaging Market, By Material Type (USD Million)

10.1. Global Pharmaceutical Glass Packaging Market Value Share and Forecast, By Material Type, 2023-2033
10.2. Type I- Borosilicate Glass
10.3. Type II- Treated Soda-Lime Glass
10.4. Type III- Regular Soda-Lime Glass
10.5. Type IV- General Purpose Soda-Lime Glass

11. Global Pharmaceutical Glass Packaging Market Forecast, 2019-2033 (USD Million)

11.1. Global Pharmaceutical Glass Packaging Market Size and Market Share

12. Global Pharmaceutical Glass Packaging Market, By Product, 2019-2033 (USD Million)

12.1. Global Pharmaceutical Glass Packaging Market Size and Market Share By Product (2019-2026)
12.2. Global Pharmaceutical Glass Packaging Market Size and Market Share By Product (2027-2033)

13. Global Pharmaceutical Glass Packaging Market, By Drug Type, 2019-2033 (USD Million)

13.1. Global Pharmaceutical Glass Packaging Market Size and Market Share By Drug Type (2019-2026)
13.2. Global Pharmaceutical Glass Packaging Market Size and Market Share By Drug Type (2027-2033)

14. Global Pharmaceutical Glass Packaging Market, By Application, 2019-2033 (USD Million)

14.1. Global Pharmaceutical Glass Packaging Market Size and Market Share By Application (2019-2026)
14.2. Global Pharmaceutical Glass Packaging Market Size and Market Share By Application (2027-2033)

15. Global Pharmaceutical Glass Packaging Market, By Material Type, 2019-2033 (USD Million)

15.1. Global Pharmaceutical Glass Packaging Market Size and Market Share By Material Type (2019-2026)
15.2. Global Pharmaceutical Glass Packaging Market Size and Market Share By Material Type (2027-2033)

16. Global Pharmaceutical Glass Packaging Market, By Region, 2019-2033 (USD Million)

16.1. Global Pharmaceutical Glass Packaging Market Size and Market Share By Region (2019-2026)
16.2. Global Pharmaceutical Glass Packaging Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
- 16.3.1. Australia
- 16.3.2. China
- 16.3.3. India
- 16.3.4. Japan
- 16.3.5. South Korea
- 16.3.6. Rest of Asia-Pacific
16.4. Europe
- 16.4.1. France
- 16.4.2. Germany
- 16.4.3. Italy
- 16.4.4. Spain
- 16.4.5. United Kingdom
- 16.4.6. Rest of Europe
16.5. Middle East and Africa
- 16.5.1. Kingdom of Saudi Arabia
- 16.5.2. United Arab Emirates
- 16.5.3. Rest of Middle East & Africa
16.6. North America
- 16.6.1. Canada
- 16.6.2. Mexico
- 16.6.3. United States
16.7. Latin America
- 16.7.1. Argentina
- 16.7.2. Brazil
- 16.7.3. Rest of Latin America

17. Company Profile

17.1. Arab Pharmaceutical Glass Co.
- 17.1.1. Company details
- 17.1.2. Financial outlook
- 17.1.3. Product summary
- 17.1.4. Recent developments
17.2. Ardagh Group S.A
- 17.2.1. Company details
- 17.2.2. Financial outlook
- 17.2.3. Product summary
- 17.2.4. Recent developments
17.3. Beatson Clark
- 17.3.1. Company details
- 17.3.2. Financial outlook
- 17.3.3. Product summary
- 17.3.4. Recent developments
17.4. Bormioli Pharma S.p.A.
- 17.4.1. Company details
- 17.4.2. Financial outlook
- 17.4.3. Product summary
- 17.4.4. Recent developments
17.5. Corning Incorporated
- 17.5.1. Company details
- 17.5.2. Financial outlook
- 17.5.3. Product summary
- 17.5.4. Recent developments
17.6. Gerresheimer AG
- 17.6.1. Company details
- 17.6.2. Financial outlook
- 17.6.3. Product summary
- 17.6.4. Recent developments
17.7. Nipro Corporation
- 17.7.1. Company details
- 17.7.2. Financial outlook
- 17.7.3. Product summary
- 17.7.4. Recent developments
17.8. Owens-Illinois, Inc.
- 17.8.1. Company details
- 17.8.2. Financial outlook
- 17.8.3. Product summary
- 17.8.4. Recent developments
17.9. Piramal Enterprises Ltd.
- 17.9.1. Company details
- 17.9.2. Financial outlook
- 17.9.3. Product summary
- 17.9.4. Recent developments
17.10. Schott AG
- 17.10.1. Company details
- 17.10.2. Financial outlook
- 17.10.3. Product summary
- 17.10.4. Recent developments
17.11. SGD S.A.
- 17.11.1. Company details
- 17.11.2. Financial outlook
- 17.11.3. Product summary
- 17.11.4. Recent developments
17.12. Shandong Medicinal Glass Co., Ltd.
- 17.12.1. Company details
- 17.12.2. Financial outlook
- 17.12.3. Product summary
- 17.12.4. Recent developments
17.13. Sisecam Group
- 17.13.1. Company details
- 17.13.2. Financial outlook
- 17.13.3. Product summary
- 17.13.4. Recent developments
17.14. Stoelzle Oberglas GmbH
- 17.14.1. Company details
- 17.14.2. Financial outlook
- 17.14.3. Product summary
- 17.14.4. Recent developments
17.15. West Pharmaceutical Services, Inc.
- 17.15.1. Company details
- 17.15.2. Financial outlook
- 17.15.3. Product summary
- 17.15.4. Recent developments
17.16. Others